APA (7th ed.) Citation

Ledingham, J., Gullick, N., Irving, K., Gorodkin, R., Aris, M., Burke, J., . . . Galloway, J. (2017). BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. Rheumatology, 56(6), 865. https://doi.org/10.1093/rheumatology/kew479

Chicago Style (17th ed.) Citation

Ledingham, Jo, et al. "BSR and BHPR Guideline for the Prescription and Monitoring of Non-biologic Disease-modifying Anti-rheumatic Drugs." Rheumatology 56, no. 6 (2017): 865. https://doi.org/10.1093/rheumatology/kew479.

MLA (9th ed.) Citation

Ledingham, Jo, et al. "BSR and BHPR Guideline for the Prescription and Monitoring of Non-biologic Disease-modifying Anti-rheumatic Drugs." Rheumatology, vol. 56, no. 6, 2017, p. 865, https://doi.org/10.1093/rheumatology/kew479.